Protein arginine methyltransferase 5 (PRMT5) and the ERK1/2 & PI3K pathways: A case for PRMT5 inhibition and combination therapies in cancer
- Tzuriel Sapir
- , David Shifteh
- , Moshe Pahmer
- , Sanjay Goel
- , Radhashree Maitra
Research output: Contribution to journal › Review article › peer-review
25
!!Link opens in a new tab
Scopus
citations